Hacker News Reader

The root of the criticism is that a sitting president wields a lot or authority and is not supposed to tout experimental treatments. The actual media spectacle we've got though...

View on HN

>The root of the criticism is that a sitting president wields a lot or authority and is not supposed to tout experimental treatments.

I hope the irony of this is not lost on readers.

"Boosters for all Americans" -Sitting President "Boosters only for people at high risk and/or over 65" -FDA a couple days later

This is interesting, and not in a good way. I'm not sure FDA as we know it can survive a two-track regime, where some medicine is fast tracked and/or cleared of legal liability. Sooner or later most new medicine will end up on the fast track, it's in the logic of large bureaucratic bodies.

https://arstechnica.com/science/2021/09/top-fda-regulators-b...

Vaccines have had special liability protection since 1986. That's nothing new.

https://www.hrsa.gov/vaccine-compensation/about/index.html

Reply on news.ycombinator.com